Differential effects of 5-HTTLPR genotypes on inhibition of negative emotional information following acute stress exposure and tryptophan challenge

Neuropsychopharmacology

Volumn 36, Issue 4, 2011, Pages 819-826

  Markus, C Rob ^a   De Raedt, Rudi ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

5 HTTLPR; emotion processing; serotonin; stress; tryptophan

Indexed keywords

PLACEBO; SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN;

ACUTE STRESS; ADULT; ARTICLE; ATTENTION; COGNITION; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; EMOTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSITIVE AND NEGATIVE AFFECT SCALE; PRIORITY JOURNAL; PROMOTER REGION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ALLELES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; GENOTYPE; HUMANS; INHIBITION (PSYCHOLOGY); QUESTIONNAIRES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PSYCHOLOGICAL; TIME FACTORS; TRYPTOPHAN;

EID: 79951514300     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.221     Document Type: Article

References (58)

1. Agren H, Reibring L (1994). PET studies of presynaptic mono-amine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 27: 2-6. (Pubitemid 24078981)
2. Beevers CG, Wells TT, Ellis AJ, McGeary J (2009). Association of the serotonin ransporter gene promoter region (5-HTTLPR) polymorphism with biased attention for emotional stimuli. J Abnorm Psychol 118: 670-681.
3. Biggio G, Fadda F, Fanni P, Tagliamonte A, Gessa GL (1974). Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci 14: 1321-1329.
4. Carpenter LL, Anderson GM, Pelton GH, Gudin JA, Kirwin PD, Price LH et al (1998). Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharma-cology 19: 26-35. (Pubitemid 28255211)
5. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389. (Pubitemid 36877077)
6. Cools R, Roberts AC, Robbins TW (2008). Serotoninergic regulation of emotional and behavioural control processes. Trends cogn Sci 12: 31-40. (Pubitemid 50012215)
7. Cowen PJ, Power AC, Ware CJ, Anderson IM (1994). 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br J Psychiatry 164: 372-379.
8. Dannlowski U, Ohrmann P, Bauer J, Deckert J, Hohoff C, Kugel H et al (2008). 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsycho-pharmacology 33: 418-424. (Pubitemid 350243352)
9. David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R et al (2005). A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 25: 2586-2590. (Pubitemid 40365170)
10. De Raedt R, Koster EHW (2010). Understanding vulnerability for depression from a cognitive neuroscience perspective: a reappraisal of attentional factors and a new conceptual framework. Cogn Affect Behav Neurosci 10: 50-70.
11. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990). Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47: 411-418. (Pubitemid 20161259)
12. Delgado PL, Miller HL, Salomon RM, Licinio J, Heninger GR, Gelenberg AJ et al (1993). Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 29: 389-396. (Pubitemid 24001308)
13. Dickerson SS, Kemeny ME (2004). Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull 130: 355-391. (Pubitemid 38614661)
14. Firk C, Markus CR (2007). Review: Serotonin by stress interaction: a susceptibility factor for the development of depression? J Psychopharmacol 21: 538-544. (Pubitemid 47106930)
15. Firk C, Markus CR (2009). Differential effects of 5-HTTLPR genotypes on mood, memory and attention bias following acute tryptophan depletion and stress exposure. Psychopharmacology (Berl) 203: 805-818.
16. Glatz K, Mossner R, Heils A, Lesch KP (2003). Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promotor-linked polymorphic region. J Neurochem 86: 1072-1078. (Pubitemid 37022183)
17. Goeleven E, De Raedt R, Baert S, Koster EH (2006). Deficient inhibition of emotional information in depression. J Affect Disord 93: 149-157. (Pubitemid 43816063)
18. Gotlib IH, Joormann J, Minor KL, Hallmayer J (2008). HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol Psychiatry 63: 847-851. (Pubitemid 351458452)
19. Gotlib IH, Neubauer YD, Joorman J (2005). Selective attention in dysphoric individuals: the role of affective interference and inhibition. Cognit ther res 29: 417-432. (Pubitemid 41225051)
20. Hariri AR, Holmes A (2006). The serotonin transporter and the genetics of affect regulation: the role of the serotonin transporter in neural function. Trends cogn Sci 10: 182-191.
21. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al (1996). Allelic variation of human serotonin transporter gene expression. J Neurochem 66: 2621-2624. (Pubitemid 26159101)
22. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA (2005). An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 29: 8-16. (Pubitemid 40129206)
23. Isowa T, Ohira H, Murashima S (2006). Immune, endocrine and cardiovascular responses to controllable and uncontrollable acute stress. Biol Psychol 71: 202-213. (Pubitemid 43082249)
24. Jacobs N, Kenis G, Peeters F, Derom C, Vlietinck R, van Os J (2006). Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry 63: 989-996. (Pubitemid 44330457)
25. Jans LA, Riedel WJ, Markus CR, Blokland A (2007). Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12: 522-543. (Pubitemid 46816766)
26. Joormann J (2004). Attentional bias in dysphoria; the role of inhibitory processes. Cogn Emot 18: 125-147. (Pubitemid 38128359)
27. Leyman L, De Raedt R, Schacht R, Koster HW (2007). Attentional biases for angry faces in unipolar depression. Psychological Medicine 37: 393-402.
28. Leyman L, De Raedt R, Vanderhasselt MA, Baeken C (2010). Effects of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex on the attentional processing of emotional information in major depression: A pilot study. Psychiatry Research (in press).
29. Lundqvist DF, A, Ohman A (1998). The karolinska directed emotional faces-KDEF.
30. Maes M, Jacobs MP, Suy E, Minner B, Leclercq C, Christiaens F et al (1990). Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients. Acta Psychiatr Scand 81: 19-23. (Pubitemid 20096983)
31. Maes M, Meltzer HY (1995). The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, pp 933-944.
32. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L et al (1998). Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44: 1090-1098. (Pubitemid 28547144)
33. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM et al (2000). A serotonin transporter gene promotor polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57: 729-738. (Pubitemid 30650106)
34. Markus C, Firk C (2009). Differential effects of tri-allelic 5-HTTLPR polymorphisms in healthy subjects on mood and stress performance after tryptophan challenge. Neuropsycho-pharmacology 34: 2667-2674.
35. Markus CR (2007). Effects of carbohydrates on brain tryptophan availability and stress performance. Biol Psychol 76: 83-90. (Pubitemid 47268631)
36. Markus CR, Firk C, Gerhardt C, Kloek J, Smolders GF (2008). Effect of different tryptophan sources on amino acids availability to the brain and mood in healthy volunteers. Psychopharmacology (Berl) 201: 107-114.
37. Moore P, Landolt HP, Seifritz E, Clark C, Bhatti T, Kelsoe J et al (2000). Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 23: 601-622.
38. Neumeister A, Hu XZ, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O et al (2006). Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 63: 978-986. (Pubitemid 44330456)
39. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al (2002). Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59: 613-620. (Pubitemid 34747241)
40. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C et al (1997). Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 94: 5308-5313. (Pubitemid 27214779)
41. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8: 828-834. (Pubitemid 43085851)
42. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J et al (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression; a meta-analysis. JAMA 301: 2462-2471.
43. Roiser JP, Blackwell AD, Cools R, Clark L, Rubinsztein DC, Robbins TW et al (2006). Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology 31: 2264-2272. (Pubitemid 44413205)
44. Ruhe HG, Mason NS, Schene AH (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 12: 331-359. (Pubitemid 46496835)
45. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J et al (2000). Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57: 174-180. (Pubitemid 30075269)
46. Scher CD, Ingram RE, Segal ZV (2005). Cognitive reactivity and vulnerability: empirical evaluation of construct activation and cognitive diatheses in unipolar depression. Psychol Rev 25: 487-510. (Pubitemid 40725816)
47. Serretti A, Kato M, De Ronchi D, Kinoshita T (2007). Meta-analysis of serotonin transporter gene promotor polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 12: 247-257. (Pubitemid 46328503)
48. Sheehan D, Lecrubier Y, Janavs J, Knapp E, Weiller E (1994). MINI International Neuropsychiatric Interview. University of South Florida: Tampa, FL.
49. Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME (2007). Increased amygdala and decreased dorsolateral prefron-tal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry 61: 198-209. (Pubitemid 46072788)
50. Uher R, McGuffin P (2008). The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13: 131-146.
51. Van Praag HM (2004). Can stress cause depression? Prog Neuropsychopharmacol Biol Psychiatry 28: 891-907. (Pubitemid 39206298)
52. van Praag HM, Korf J, Puite J (1970). 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225: 1259-1260.
53. Walderhaug E, Magnusson A, Neumeister A, Lappalainen J, Lunde H, Refsum H et al (2007). Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people. Biol Psychiatry 62: 593-599. (Pubitemid 47314384)
54. Watson D, Clark LA, Tellegen A (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54: 1063-1070.
55. Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL (2006). Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 11: 224-226.
56. Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A et al (2006). Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 188: 210-215. (Pubitemid 43341646)
57. Williams WA, Shoaf SE, Hommer D, Rawlings R, Linnoila M (1999). Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 72: 1641-1647. (Pubitemid 29140839)
58. Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA et al (2006). Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 163: 1588-1593. (Pubitemid 44465760)